These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 4397165

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Importance and pathogenesis of abnormal movements during L-dopa therapy of Parkinson's disease.
    Barbeau A.
    Neurology; 1970 Apr; 20(4):377. PubMed ID: 5534982
    [No Abstract] [Full Text] [Related]

  • 3. L-dopa induced dyskinesias in 152 patients with Parkinson's disease.
    Mones RJ, Elizan TS, Siegel G.
    Trans Am Neurol Assoc; 1970 Apr; 95():286-7. PubMed ID: 5514393
    [No Abstract] [Full Text] [Related]

  • 4. An analysis of L-dopa-induced dyskinesias in 152 cases of Parkinson's disease.
    Mones RJ, Elizan TS, Siegel GJ.
    Neurology; 1970 Apr; 20(4):405-6. PubMed ID: 5535050
    [No Abstract] [Full Text] [Related]

  • 5. L-dopa therapy in Parkinson's disease.
    Lipman IJ.
    Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor].
    Siegfried J, Klaiber R, Perret E, Ziegler WH.
    Dtsch Med Wochenschr; 1969 Dec 26; 94(52):2678-81. PubMed ID: 4903342
    [No Abstract] [Full Text] [Related]

  • 7. Parkinson's disease treated with L-dopa. Three-year follow-up report.
    Mones RJ.
    N Y State J Med; 1972 Nov 15; 72(22):2749-50. PubMed ID: 4510706
    [No Abstract] [Full Text] [Related]

  • 8. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University).
    Gutmann L, Martin JD, Gutrecht JA.
    W V Med J; 1970 Apr 15; 66(4):109-11. PubMed ID: 5264660
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G, Castaigne P, Lhermitte F, Beck H, Guillard A, Marteau R, Pepin B, Rondot P, Raphy B.
    Rev Neurol (Paris); 1970 Feb 15; 122(2):89-102. PubMed ID: 4931719
    [No Abstract] [Full Text] [Related]

  • 10. [Collateral effects of therapy with L-dopa in Parkinson's disease].
    Gomirato G, Perfetti CC, Ecari U.
    Sist Nerv; 1970 Feb 15; 22(2):67-73. PubMed ID: 5504559
    [No Abstract] [Full Text] [Related]

  • 11. [Problems and therapy of L-DOPA-induced dyskinesias].
    Völler GW, Deze J, Gundlach U, Muschard F.
    Nervenarzt; 1972 Nov 15; 43(11):584-6. PubMed ID: 4564994
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical study of L-dopa in Parkinson's disease].
    Franken L, Noel G, Lhoas JP, Meyers C, Noel P, Ectors M.
    Brux Med; 1972 Dec 15; 52(12):851-60. PubMed ID: 4575350
    [No Abstract] [Full Text] [Related]

  • 13. [Preliminary impressions of the therapeutic effectiveness of L-dopa in Parkinson's disease].
    Buscaino GA, Campanella G.
    Sist Nerv; 1970 Dec 15; 22(2):82-91. PubMed ID: 5504561
    [No Abstract] [Full Text] [Related]

  • 14. [Abnormal movements induced by L-Dopa and dopamine metabolism disorders].
    Lhermitte F, Rosa A, Comoy E, Bohuon C.
    Rev Neurol (Paris); 1973 Dec 15; 129(6):313-24. PubMed ID: 4794176
    [No Abstract] [Full Text] [Related]

  • 15. Side effects of L-dopa treatment.
    Greenburg J.
    Pa Med; 1971 Apr 15; 74(4):55-6. PubMed ID: 5147645
    [No Abstract] [Full Text] [Related]

  • 16. [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].
    Tissot R, de Ajuriaguerra J.
    Nouv Presse Med; 1973 Feb 03; 2(5):315-6. PubMed ID: 4686226
    [No Abstract] [Full Text] [Related]

  • 17. Failures of L-dopa.
    Paulson GW.
    Ohio State Med J; 1973 Dec 03; 69(12):896-8. PubMed ID: 4769406
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].
    Tissot R, Gaillard JM, Guggisberg M, Gauthier G, de Ajuriaguerra J.
    Presse Med (1893); 1969 Apr 05; 77(17):619-22. PubMed ID: 5785081
    [No Abstract] [Full Text] [Related]

  • 19. [Two years experience with L-DOPA in association with a decarboxylase inhibitor].
    Siegfried J.
    Rev Neurol (Paris); 1970 Apr 05; 122(4):243-8. PubMed ID: 5472041
    [No Abstract] [Full Text] [Related]

  • 20. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD.
    Neurology; 1970 Dec 05; 20(12):Suppl:6-13. PubMed ID: 4921587
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.